MiDOG Animal Diagnostics today announced the launch of its enhanced Whole Genome Sequencing diagnostic service, significantly expanding its sequencing platform to provide one of the most comprehensive ...

Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a well-recognized cause of bacterial pneumonia, resulting in increased morbidity and mortality worldwide. Traditional antibiotics face ...

Gothenburg, March 11, 2023 - Elicera Therapeutics AB (publ) ("Elicera"), a clinical stage cell and gene therapy company developing next-generation therapies based on oncolytic viruses and CAR T-cells ...

An international team of researchers has modified a probiotic yeast to make it safer for use by immunocompromised people, older adults and infants. Testing in an animal model found that the modified ...

VAPING could be to blame for Kent’s “explosive” meningitis outbreak experts revealed today, after two more cases were ...

Genetically modified probiotic yeast S. boulardii can prevent bloodstream infections, making it safer for immunocompromised patients, including the elderly and infants.

Investigating microplastics in agriculture reveals their effects on soil microbes and viruses, crucial for developing strategies for ecosystem restoration.

Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial ...

A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), ...

BV500: Entered global research collaboration with Shionogi for broad-spectrum non-tuberculous mycobacteria Successful IPO funding operations into 2028 with BV100 Phase 3 read-out by the end of 2027 ...

Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase ...